<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03955289</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0270</org_study_id>
    <nct_id>NCT03955289</nct_id>
  </id_info>
  <brief_title>Treatment of Foot and Leg Ulcers Using a Laser</brief_title>
  <official_title>Treatment of Foot and Leg Ulcers Using a Laser</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to do a retrospective chart review on patients who underwent laser
      treatment for their foot ulcer at the UT Southwestern wound clinic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators plan to do a retrospective chart review on patients who underwent laser
      treatment for their foot ulcer at the UT Southwestern wound clinic starting on May 17, 2018
      to November 13, 2018. The investigators chose this date because that is the first time laser
      treatments were performed in the clinic. The investigators will collect the following data
      points:

        -  Ulcer etiology

        -  Ulcer location

        -  Prior ulcer treatment type and duration, and wound measurements/characteristics

        -  Wound size 4-6 weeks prior to laser treatment; at treatment time; and then each follow
           up measurement healed or x weeks

        -  eGFR

        -  Albumin

        -  Last A1c-Presence/absence of DM

        -  Amputation history

        -  Vascular status via ABI's

        -  Identify comorbidities

        -  Identify associated encounters in the patients such as complications (i.e. infection),
           related readmissions The investigators will identify this information from patient
           charts (EPIC EMR).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improved healing rate to time to healing</measure>
    <time_frame>4 weeks</time_frame>
    <description>Wounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s). Improved healing rate to time to healing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decreased complications in diabetic foot ulcers, i.e. infection, hospital admission, amputation</measure>
    <time_frame>4 weeks</time_frame>
    <description>Wounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s).
Decreased complications in diabetic foot ulcers, i.e. infection, hospital admission, amputation</description>
  </secondary_outcome>
  <enrollment type="Actual">34</enrollment>
  <condition>Diabetic Foot Ulcer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the investigators with foot ulcers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who underwent laser treatment for their foot ulcer at the UT Southwestern
             wound clinic starting on May 17, 2018 to November 13, 2018

        Exclusion Criteria:

          -  not meeting inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Lavery, DPM MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://sciton.com/physicians/profractional</url>
    <description>2. Sciton Inc. (n.d.). [Brochure]. Author. Retrieved November 8, 2018</description>
  </link>
  <link>
    <url>https://www.researchgate.net/publication/299493475_Erbium-YAG_laser_therapy_-_analysis_of_more_than_1200_treatments</url>
    <description>Wollina, Uwe. (2016). Erbium-YAG laser therapy - analysis of more than 1,200 treatments. Journal of Global Dermatology. 3. 10.15761/GOD.1000171</description>
  </link>
  <reference>
    <citation>Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37(3):651-8. doi: 10.2337/dc13-2176. Epub 2013 Nov 1. Erratum in: Diabetes Care. 2014 Sep;37(9):2660.</citation>
    <PMID>24186882</PMID>
  </reference>
  <reference>
    <citation>Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg. 1997 Aug;23(8):685-7.</citation>
    <PMID>9256915</PMID>
  </reference>
  <reference>
    <citation>Mezzana P, Sonnino M, Madonna Terracina FS, Valeriani M. Treatment of atrophic scars with Er:YAG laser: our experience. Acta Chir Plast. 2001;43(1):26-8.</citation>
    <PMID>11370255</PMID>
  </reference>
  <reference>
    <citation>Wollina U, Konrad H, Karamfilov T. Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther. 2001 Jun;3(2):63-6.</citation>
    <PMID>11798495</PMID>
  </reference>
  <reference>
    <citation>Gurel MS, Aral BB. Effectiveness of erbium:YAG laser and cryosurgery in seborrheic keratoses: Randomized, prospective intraindividual comparison study. J Dermatolog Treat. 2015 Oct;26(5):477-80. doi: 10.3109/09546634.2015.1024597. Epub 2015 Mar 23.</citation>
    <PMID>25798694</PMID>
  </reference>
  <reference>
    <citation>Alsaad SM, Ross EV, Smith WJ, DeRienzo DP. Analysis of Depth of Ablation,Thermal Damage, Wound Healing, and Wound Contraction With Erbium YAG Laser in a Yorkshire Pig Model. J Drugs Dermatol. 2015 Nov;14(11):1245-52.</citation>
    <PMID>26580873</PMID>
  </reference>
  <reference>
    <citation>Madni TD, Lu KB, Imran JB, Clark AT, Hoopman JE, Kenkel JM, Phelan HA. Chronic burn wound treatment by Erbium: YAG fractional ablation: First described report and literature review. Burns. 2019 Feb;45(1):256-258. doi: 10.1016/j.burns.2018.10.001. Epub 2018 Oct 17. Review.</citation>
    <PMID>30342793</PMID>
  </reference>
  <reference>
    <citation>Phillips TJ, Morton LM, Uebelhoer NS, Dover JS. Ablative Fractional Carbon Dioxide Laser in the Treatment of Chronic, Posttraumatic, Lower-Extremity Ulcers in Elderly Patients. JAMA Dermatol. 2015 Aug;151(8):868-71. doi: 10.1001/jamadermatol.2015.0645.</citation>
    <PMID>25946007</PMID>
  </reference>
  <reference>
    <citation>Krakowski AC, Diaz L, Admani S, Uebelhoer NS, Shumaker PR. Healing of chronic wounds with adjunctive ablative fractional laser resurfacing in two pediatric patients. Lasers Surg Med. 2016 Feb;48(2):166-9. doi: 10.1002/lsm.22398. Epub 2015 Aug 7.</citation>
    <PMID>26251161</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 16, 2019</study_first_submitted>
  <study_first_submitted_qc>May 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2019</study_first_posted>
  <last_update_submitted>May 17, 2019</last_update_submitted>
  <last_update_submitted_qc>May 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Larry Lavery</investigator_full_name>
    <investigator_title>Professor and Director of Research</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

